AI MARKET SCANNING

Carisma Therapeutics, Inc.

AVG HISTORICAL GAP +0.94%
MAX GAP RECORD +5.00%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CARM
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
+0.73%
Mar 31, 2025 Earnings Release 2025-03-31 (AFTER CLOSE)
-3.23%
Nov 07, 2024 Earnings Release 2024-11-07 (BEFORE OPEN)
-2.70%
Aug 08, 2024 Earnings Release 2024-08-08 (BEFORE OPEN)
+5.00%
Apr 02, 2024 Earnings Release 2024-04-02 (BEFORE OPEN)
+2.39%
Nov 09, 2023 Earnings Release 2023-11-09 (BEFORE OPEN)
+3.69%
Aug 10, 2023 Earnings Release 2023-08-10 (BEFORE OPEN)
+0.72%
May 11, 2023 Earnings Release 2023-05-11 (BEFORE OPEN)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.6%
Bullish Gaps (3)
Bearish Gaps (2)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CARM

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗